You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

BSS PLUS Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Bss Plus patents expire, and what generic alternatives are available?

Bss Plus is a drug marketed by Alcon and is included in one NDA.

The generic ingredient in BSS PLUS is calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate. There are two hundred and eighty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BSS PLUS?
  • What are the global sales for BSS PLUS?
  • What is Average Wholesale Price for BSS PLUS?
Summary for BSS PLUS
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 168
What excipients (inactive ingredients) are in BSS PLUS?BSS PLUS excipients list
DailyMed Link:BSS PLUS at DailyMed
Drug patent expirations by year for BSS PLUS

US Patents and Regulatory Information for BSS PLUS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon BSS PLUS calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate SOLUTION;IRRIGATION 018469-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for BSS PLUS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon BSS PLUS calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate SOLUTION;IRRIGATION 018469-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Alcon BSS PLUS calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate SOLUTION;IRRIGATION 018469-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for BSS PLUS

See the table below for patents covering BSS PLUS around the world.

Country Patent Number Title Estimated Expiration
Ireland 54082 OPHTHALMIC IRRIGATING SOLUTION ⤷  Sign Up
Ireland 822327 ⤷  Sign Up
Denmark 159099 ⤷  Sign Up
Mexico 160012 PROCEDIMIENTO PARA PREPARAR UNA COMPOSICION OFTALMICA ⤷  Sign Up
Argentina 228986 METODO PARA PROPORCIONAR UNA SOLUCION CLARA,ESTERIL Y ESTABLE ⤷  Sign Up
Japan H0322369 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for BSS PLUS

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2957286 132019000000021 Italy ⤷  Sign Up PRODUCT NAME: PATIROMER SORBITEX CALCIUM E QUALSIASI SUO SALE O DERIVATO(VELTASSA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1179, 20170721
2365988 122018000012 Germany ⤷  Sign Up PRODUCT NAME: PATIROMER SORBITEX CALCIUM UND SALZE DAVON IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719
2365988 LUC00061 Luxembourg ⤷  Sign Up PRODUCT NAME: PATIROMER SORBITEX CALCIUM ET TOUS LES SELS ET DERIVES DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
0521471 SPC/GB03/033 United Kingdom ⤷  Sign Up PRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321
2957286 CA 2018 00043 Denmark ⤷  Sign Up PRODUCT NAME: PATIROMER SORBITEX CALCIUM AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179/001-009 20170721
0247633 62/1997 Austria ⤷  Sign Up PRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.